Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 122Myeloid 62Lymphoid 21Thoracic 11Plasma cell 8Gastrointestinal 7Genitourinary 5Classical hematology 4Breast 4Head & Neck 3Tumor-Agnostic 2Gynecologic 2CNS 2Sarcoma 1Other solid neoplasm 1Dermatologic 1

Conditions

Sarcoma 1Mesothelioma 1

Interventions

Temozolomide 63Cyclophosphamide 55Radiotherapy 53Bevacizumab 50Doxorubicin 48Ifosfamide 33pazopanib 28fludarabine phosphate 28Etoposide 27Radiation 24Gemcitabine 24pembrolizumab 23Sirolimus 23Sunitinib 22Filgrastim 22Irinotecan 21Whole-Body Irradiation 20Peripheral Blood Stem Cell Transplantation 20Mycophenolic Acid 20Imatinib Mesylate 20Vincristine 19Magnetic Resonance Spectroscopy 18Sorafenib 16Methotrexate 16Busulfan 16Melphalan 15Carboplatin 15Docetaxel 14Cyclosporine 14temsirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Azacitidine × Sarcoma × Clear all
NCT00629343 2025-06-05

Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide

Columbia University

Phase 1 Completed
27 enrolled 7 charts
Other solid neoplasmSarcomaThoracic

Mesothelioma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡